BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 05, 2022 at 01:22 am IST
Share
BioLASCO Taiwan Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 56.36 million compared to TWD 60.31 million a year ago. Net income was TWD 11.03 million compared to TWD 10.67 million a year ago. Basic earnings per share was TWD 0.43 compared to TWD 0.42 a year ago. Diluted earnings per share was TWD 0.43 compared to TWD 0.42 a year ago.
For the six months, sales was TWD 106.81 million compared to TWD 109.21 million a year ago. Net income was TWD 17.95 million compared to TWD 17.73 million a year ago. Basic earnings per share was TWD 0.7 compared to TWD 0.69 a year ago. Diluted earnings per share was TWD 0.7 compared to TWD 0.69 a year ago.
BioLASCO Taiwan Co., Ltd. is a Taiwan-based company mainly engaged in the production of Specific Pathogen Free (SPF) laboratory animals and the high-value special-mode experimental animals, as well as the introduction and production of highly-applicable disease-mode animals. The company also provides equipment related to feeding, supplies and testing platform, life science research and pharmaceutical development services.